Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
C Venkata S Ram & Martin A Rudmann. (2007) Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stroke and cognitive decline. Expert Review of Cardiovascular Therapy 5:6, pages 1003-1011.
Read now
Read now
Alejandro De La Sierra, Anna Munoz, Emma Arcos, Juan Salvador Lopez & Jordi Relats. (2004) Effect of eprosartan on pulse pressure and blood pressure components in patients with ksolated systolic hypertension. Blood Pressure 13:2, pages 5-10.
Read now
Read now
Egbert H. E. Biesheuvel & Ludwig A. Hothorn. (2003) Protocol Designed Subgroup Analyses in Multiarmed Clinical Trials: Multiplicity Aspects. Journal of Biopharmaceutical Statistics 13:4, pages 663-673.
Read now
Read now
Luis Ruilope & Bodo Jager. (2003) Eprosartan for the treatment of hypertension. Expert Opinion on Pharmacotherapy 4:1, pages 107-114.
Read now
Read now
Barton Levine. (2001) Eprosartan Provides Safe and Effective Long-term Maintenance of Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension. Current Medical Research and Opinion 17:1, pages 8-17.
Read now
Read now
Articles from other publishers (17)
Gino Seravalle & Guido Grassi. 2023. Endocrine Hypertension. Endocrine Hypertension
63
75
.
Fawaz F. Alharbi, Anzhelika A.V. Kholod, Patrick C. Souverein, Ronald H. Meyboom, Mark C.H. de Groot, Anthonius de Boer & Olaf H. Klungel. (2017) The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase. Fundamental & Clinical Pharmacology.
Crossref
Crossref
Benjamin J. Powers, Remy R. Coeytaux, Rowena J. Dolor, Vic Hasselblad, Uptal D. Patel, William S. YancyJr.Jr., Rebecca N. Gray, R. Julian Irvine, Amy S. Kendrick & Gillian D. Sanders. (2011) Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information. Journal of General Internal Medicine 27:6, pages 716-729.
Crossref
Crossref
Ettore Ambrosioni, Michele Bombelli, Giovanni Cerasola, Francesco Cipollone, Claudio Ferri, Irene Grazioli, Cristiana Leprotti, Giuseppe Mancia, Gabriella Melzi, Amedeo Mugellini, Giuseppe Mulè, Giuseppe Palasciano, Antonio Salvetti & Bruno Trimarco. (2010) Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). Advances in Therapy 27:6, pages 365-380.
Crossref
Crossref
G Neil Thomas, Paul Chan & Brian Tomlinson. (2006) The Role of Angiotensin II Type 1 Receptor Antagonists in Elderly Patients with Hypertension. Drugs & Aging 23:2, pages 131-155.
Crossref
Crossref
L. Michael Prisant. 2005. Hypertension in the Elderly. Hypertension in the Elderly
349
367
.
H A Punzi & C F Punzi. (2004) Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study. Journal of Human Hypertension 18:9, pages 655-661.
Crossref
Crossref
Thomas Unger & Bernward A. SchölkensM. de Gasparo. 2004. Angiotensin Vol. II. Angiotensin Vol. II
417
451
.
S Y S Wong, G T McInnes & T M MacDonald. (2003) Why not prescribe the best drugs for hypertension now?. Journal of Human Hypertension 17:7, pages 505-511.
Crossref
Crossref
Michael B??hm & Alisia Sachse. (2002) Safety and Tolerability of Eprosartan in Combination with Hydrochlorothiazide. Drug Safety 25:8, pages 599-611.
Crossref
Crossref
Angela Cheng-Lai. (2002) Eprosartan. Heart Disease, pages 54-59.
Crossref
Crossref
E Breeze, EC Rake, MD Donoghue & AE Fletcher. (2001) Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension. Journal of Human Hypertension 15:12, pages 857-862.
Crossref
Crossref
M.A. Gálvez-Múgica, J. Novalbos, S. Gallego-Sandín, A.G. García & F. Abad-Santos. (2001) Eprosartán en el tratamiento de la hipertensión arterial. Hipertensión y Riesgo Vascular 18:6, pages 276-284.
Crossref
Crossref
Norman K. Hollenberg. (2001) Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure. Current Hypertension Reports 3:1, pages S25-S28.
Crossref
Crossref
Neil H. Shusterman. (1999) Safety and efficacy of eprosartan, a new angiotensin II receptor blocker. American Heart Journal 138:3, pages S238-S245.
Crossref
Crossref
Michael Weber. (2012) Clinical Efficacy of Eprosartan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:4P2.
Crossref
Crossref
Irene Gavras & Haralambos Gavras. (2012) Safety and Tolerability of Eprosartan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:4P2.
Crossref
Crossref